Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Endovenous laser ablation (EVLA) may leads to higher technical success (< 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
Endovenous laser ablation (EVLA) showed no clear difference in recurrence (< 5 years) compared with SFJ ligation and stripping (HL/S) (moderate certainty).
Endovenous laser ablation (EVLA) showed no clear difference in long‐term recurrence (> 5 years) compared with SFJ ligation and stripping (HL/S) (moderate certainty).
Radiofrequency ablation (RFA) showed no clear difference in technical success (< 5 years) compared with mechanochemical ablation (MOCA) (low certainty).
Radiofrequency ablation (RFA) showed no clear difference in recurrence (< 5 years) compared with mechanochemical ablation (MOCA) (low certainty).
The review found no eligible studies for this question.
Radiofrequency ablation (RFA) showed no clear difference in technical success (< 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
Radiofrequency ablation (RFA) showed no clear difference in recurrence (< 5 years) compared with SFJ ligation and stripping (HL/S) (moderate certainty).
Radiofrequency ablation (RFA) may leads to lower long‐term recurrence (> 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
Endovenous laser ablation (EVLA) showed no clear difference in recurrence (< 5 years) compared with radiofrequency ablation (RFA) (low certainty).
Ultrasound‐guided foam sclerotherapy (UGFS) may leads to lower technical success (< 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
Ultrasound‐guided foam sclerotherapy (UGFS) showed no clear difference in recurrence (< 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
Ultrasound‐guided foam sclerotherapy (UGFS) showed no clear difference in long‐term recurrence (≥ 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).